p1446a-05
Showing 1 - 4 of 4
Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Trial in Boston, Lebanon (P1446A-05)
Suspended
- Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
- P1446A-05
-
Boston, Massachusetts
- +1 more
Sep 2, 2014
Advanced or Inoperable Malignant Melanoma With BRAF Mutation Trial in United States (P1446A-05, Vemurafenib (Zelboraf®))
Suspended
- Advanced or Inoperable Malignant Melanoma With BRAF Mutation
- P1446A-05
- Vemurafenib (Zelboraf®)
-
South San Francisco, California
- +3 more
Sep 3, 2014
Solid Tumor, Hematologic Malignancy Trial in Mumbai, Pune, Jaipur (P1446A-05)
Completed
- Solid Tumor
- Hematologic Malignancy
- P1446A-05
-
Mumbai, Maharashtra, India
- +4 more
Nov 20, 2012
Cancer Trial in Canada (P1446A-05)
Completed
- Cancer
- P1446A-05
-
Calgary, Alberta, Canada
- +3 more
Nov 21, 2012